BIOX Earnings & Financial Statements
Bioceres Crop Solutions Corp.
$0.30
-$0.02(-7.66%)
34
Overall
--
Value
27
Tech
42
Quality
Market Cap
$19.15M
Volume
239.81K
52W Range
$0.30 - $2.19
Target Price
$2.00
BIOX earnings and financial statements: Bioceres Crop Solutions Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly.
BIOX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $335.11M | $464.87M | $419.45M | $43.34M | $209.53M |
| Cost of revenue | $203.42M | $278.22M | $235.46M | $10.16M | -$118.64M |
| Operating income | -$32.84M | $37.86M | $57.83M | $6.43M | $13.60M |
| EBITDA | -$6.55M | $54.22M | $36.24M | $8.78M | -$907.4K |
| Net income | -$55.42M | $5.29M | -$9.41M | $5.52M | $14.23M |
| EPS (diluted) | $-0.88 | $0.07 | $0.30 | $-0.09 | $-0.18 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $763.65M | $852.55M | $818.06M | $69.04M | $394.59M |
| Total liabilities | $468.43M | $501.17M | $487.56M | $53.84M | $304.30M |
| Shareholders’ equity | $265.44M | $315.04M | $298.59M | $15.20M | $67.74M |
| Cash and equivalents | $32.70M | $44.47M | $48.13M | $32.91M | $30.66M |
| Long-term debt | $47.73M | $131.08M | $145.91M | $9.30M | $48.38M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $49.91M | $41.72M | $2.59M | -$9.98M | -$6.21M |
| Capital expenditure | - | - | - | -$614.0K | -$13.98M |
| Free cash flow | $35.30M | $18.93M | -$19.84M | -$10.59M | -$20.19M |
| Dividends paid | $72.1K | $174.8K | $452.1K | - | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIOX | $0.30 | -7.7% | 239.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bioceres Crop Solutions Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW